Job Creation and Inclusion in Cell and Gene Therapy

Many roles exist at Cell and Gene Therapy companies on multiple education levels. What jobs, both scientific and non-scientific, are being created? What work is being done to ensure inclusion at all levels? How many jobs could be created in the next 3-5 years? come hear from experts on why job creation and inclusion in this industry is critical for the region.

Panelists:
Kristy Shuda McGuire, Associate Dean of Biomedical Studies and Associate Professor at the Wistar Institute
Lamont Terrell – Inclusion & Diversity Lead, Pharma R&D at GSK
Amber Wynne – Head of Diversity, Equity and Inclusion at Spark Therapeutics, Inc.

Moderator:
Lamont Robinson, Director of Supplier Diversity at AmerisourceBergen